Infusion Of Delphinium Glaucum
Also known as: Sierra larkspur, tall larkspur, botanical extract, plant-based supplement, herbal, Delphinium glaucum
Overview
Delphinium glaucum, commonly known as Sierra larkspur or tall larkspur, is a perennial flowering plant indigenous to the mountainous regions of North America, typically thriving in meadows and wet environments. It belongs to the genus Delphinium, which is recognized for species containing bioactive alkaloids with potential pharmacological properties. Historically, the plant has been noted for its toxicity to mammals, including causing paralysis in livestock, primarily due to these alkaloids. Research specifically on D. glaucum as a supplement ingredient is extremely limited, with most pharmacological studies focusing on related species like Delphinium denudatum. The research maturity level for D. glaucum as a human supplement is very preliminary, lacking systematic reviews or meta-analyses to support its use.
Benefits
There is no direct clinical evidence or randomized controlled trials (RCTs) supporting the use of Delphinium glaucum infusion for human supplementation. While related species, such as Delphinium denudatum, have shown some anxiolytic (anti-anxiety) effects in animal models, these findings cannot be directly extrapolated to D. glaucum. For instance, hydroalcoholic root extracts of D. denudatum demonstrated significant anxiolytic activity comparable to diazepam in rodents at doses of 200-400 mg/kg. These effects are generally attributed to the presence of alkaloids, flavonoids, and other phytochemicals. However, the lack of direct evidence for D. glaucum, coupled with significant toxicity concerns due to poisonous alkaloids, severely limits its safe use without rigorous safety evaluation.
How it works
The proposed mechanism of action for Delphinium species, based on studies of related plants, involves the interaction of their alkaloids with the nervous system. These alkaloids may modulate GABAergic pathways, which could explain the anxiolytic effects observed in some animal models. Additionally, the presence of flavonoids and tannins in these plants might contribute to antioxidant and neuroprotective effects. However, the specific molecular targets and pathways for Delphinium glaucum infusion remain largely uncharacterized. Furthermore, the bioavailability and absorption profiles of the alkaloids found in Delphinium species are not well documented, making it difficult to fully understand their systemic effects.
Side effects
Delphinium glaucum is known to be toxic to mammals, causing paralysis and other severe adverse effects in livestock. There is no human safety data or clinical toxicity profiles available for D. glaucum. While acute toxicity studies on a related species, D. denudatum, in animals showed no mortality up to 2000 mg/kg, this finding cannot be generalized to D. glaucum without direct testing. Due to its known toxicity in animals, human use without controlled clinical evaluation is strongly not recommended. The potential for drug interactions and contraindications is unknown but could be significant, given the presence of neuroactive alkaloids. Consumers should be aware of the high risk of poisoning and paralysis associated with this plant.
Dosage
There are no established dosing guidelines for Delphinium glaucum infusion or extracts in humans. Animal studies on related species, such as D. denudatum, used hydroalcoholic extracts at doses of 200-400 mg/kg for anxiolytic effects. However, these findings are not directly applicable to D. glaucum or human consumption. Given the significant toxicity concerns associated with Delphinium species, any attempt at human dosing would require extremely careful titration and extensive clinical supervision, which is currently lacking. Without comprehensive safety and efficacy data from human trials, any use of D. glaucum is considered unsafe and not recommended.
FAQs
Is Delphinium glaucum safe for human supplementation?
No conclusive evidence supports its safety for human consumption. Known toxicity in mammals, including paralysis in livestock, suggests extreme caution and contraindicates its use.
Does it have proven health benefits?
No direct human studies or systematic reviews exist for D. glaucum. While related species show anxiolytic effects in animals, these cannot be directly applied to D. glaucum or human health.
Can it be used for anxiety or neurological conditions?
Only preliminary animal data from related species suggest potential anxiolytic effects. There are no clinical trials for D. glaucum, making its use for such conditions unsupported and risky.
What are the risks of using Delphinium glaucum?
The primary risks include potential poisoning and paralysis, as observed in mammals. Human safety is unknown, and severe adverse effects are a significant concern.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6010653/ – This animal study investigated the psychopharmacological effects of Delphinium denudatum root extract in rodents. It found significant anxiolytic activity comparable to diazepam at doses of 400 mg/kg and reported no acute toxicity up to 2000 mg/kg. However, this research was conducted on a related species and not D. glaucum, limiting its direct applicability.
- https://www.frontiersin.org/journals/marine-science/articles/10.3389/fmars.2022.865834/full – This microbiome analysis, while mentioning a related species (Dipterygium glaucum), focused on identifying unique metabolic pathways in environmental samples. It noted the toxicity of Delphinium species to mammals, providing indirect relevance to the safety profile but not directly to supplementation or pharmacological effects of D. glaucum.
- https://floranorthamerica.org/Delphinium_glaucum – This source provides botanical information on Delphinium glaucum, confirming its classification as a perennial flowering plant native to North American mountainous regions. It serves as a foundational reference for the plant's identity and habitat, supporting the overview section.